Wearable Medical Devices, Big Data, and Parkinson’s Disease Research

Parkinson’s disease, historically has been challenging to study. This is mostly due to the fact that the data collected was subjective because the measurement strategies of the disease haven’t changed much in the nearly 200 years since Parkinson’s was discovered. But technology giant, Intel Corporation, is working to change that through the development of wearable medical devices that can measure undetectable changes over time. By using these sensing devices, the right data is shared from the sensor back to a central repository where it is analyzed. It’s a revolutionary step forward in Parkinson’s research and is a glimpse of what is possible on a much larger scale to analyze the data of huge populations to develop treatments for other diseases.

Discover More


Learn about wearable technology to advance Parkinson's research in this white paper.

Click to read


BIT FEED: Every Friday Intel IT Center's Bit Feed recaps the week's hottest IT headlines�with a bit of Intel expert perspective�so you get quick bits of insight on what today's developments  mean for tomorrow's technology. BIT FEED: Every Friday Intel IT Center's Bit Feed recaps the week's hottest IT headlines�with a bit of Intel expert perspective�so you get quick bits of insight on what today's developments  mean for tomorrow's technology. BIT FEED: Every Friday Intel IT Center's Bit Feed recaps the week's hottest IT headlines�with a bit of Intel expert perspective�so you get quick bits of insight on what today's developments  mean for tomorrow's technology.
Get the Intel IT Center's insight behind each week's IT headlines. Sample a bit of Intel's perspective on this week's developments and then subscribe today:
Never miss out on IT news

Success!

Thanks for signing up for Bit Feed. Your email with the Intel perspective on the week's top Analytics stories will arrive every Friday morning – enjoy!

We're sorry, there's been a problem submitting your information. Please try again.

By signing up, you agree to our Terms of Use and Intel Privacy Notice.